Asston Pharmaceuticals LimitedBSE: APL

Asston Pharmaceuticals Limited Press Release Jul 02 2026

· Issued by Asston Pharmaceuticals Limited via BSE India

Filed with BSE · · 4 pages · English

Subject: Outcome of Board Meeting Scrip Code: 544445 ISIN: INE0SJX01015 • Issue of up to 24,10,431 (Twenty-Four Lakh Ten Thousand Four Hundred and Thirty-One) Equity Shares having a face value of ₹10/- (Rupees Ten Only) each at an issue price of ₹115/- (Rupees One Hundred and Fifteen Only) per equity share, including a premium of ₹105/- (Rupees One Hundred and Five Only) per equity share, aggregat

Asston Pharmaceuticals Limited on 6ix

Earlier from Asston Pharmaceuticals

Later from Asston Pharmaceuticals

All Asston Pharmaceuticals news releases